ADDAX Biosciences is a spin-off of the University of Turin born in 2017 after a long research activity on pathological tissue fixation. It aims to eradicate Formalin – a carcinogenic substance – from hospitals, research centres and laboratories, and replace it with GAF®, an innovative product that provides diagnosis accuracy without exposing healthcare professionals to the risk of
developing work-related diseases and cancers.
- About
- Participants
- Partnering
- Exhibition
- Pitches
- Conferences
- Hosted Events
- Healthy Teeth project
- Advancing Data Incorporation and Interoperability for Cancer Image Europe
- The augmented human: technological advances and research partnerships
- MICROPLAITE project
- DIAMOND project
- Awards Ceremony – PUI Lille Innovation Contest
- Interested in hosting your own event?
- 2023 Hosted Event
- Previous editions
- Registration
- Practical information